VSGN - Vasogen Inc. (Naz GM)

[Klipper22]

Low floater. Nice set-up.

Vasogen Inc.
2505 Meadowvale Boulevard
Mississauga, ON L5N 5S2
Canada
Phone: 905-817-2000
Fax: 905-569-9231
Web Site: http://www.vasogen.com

Sector: Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 104

BUSINESS SUMMARY
Vasogen, Inc. engages in the research and development of therapies for the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It markets its lead product candidate, Celacade, a device-based therapy for the treatment of chronic heart failure in the European Union. Celacade is also in various late-stage clinical developments in the United States. The company also develops a class of drugs based on synthetic three-dimensional phospholipid-based structures with specific groups of surface molecules, including VP025 for the treatment of neuro-inflammatory disorders and for certain neurodegenerative disorders, including Parkinson's disease, memory loss models, ALS, and retinal inflammation in a model of diabetes; and VP015 to treat other inflammatory conditions. Vasogen was founded in 1980 and is headquartered in Mississauga, Ontario.

Shares Outstanding: 22.40M
Float: 22.27M